Richard L. Lindstrom

Lindstrom’s Perspective

Lindstrom's Perspective

Simple tests still have a place in measuring IOL surgery outcomes

Ocular Surgery News U.S. Edition, June 25, 2014
Richard L. Lindstrom, MD
New IOLs that allow functional vision at more than one distance continue to be developed. In general, we and our patients are first interested in the…
Lindstrom's Perspective

Ophthalmologists at forefront of monitoring, treating diabetes

Ocular Surgery News U.S. Edition, June 10, 2014
Richard L. Lindstrom, MD
Diabetes affects 382 million people worldwide, fully 3.3% of the population. The number of diabetics is expected to double in the next 20…
Lindstrom's Perspective

Help of pediatric ophthalmologist crucial in care of intermittent exotropia

Ocular Surgery News U.S. Edition, May 25, 2014
Richard L. Lindstrom, MD
Exotropia occurs in about 1% of the population. The most common form is intermittent exotropia, representing more than 75% of cases…
Lindstrom's Perspective

ICD-10 brings uncertainty, extra work for ophthalmic practices

Ocular Surgery News U.S. Edition, April 25, 2014
Richard L. Lindstrom, MD
To be direct, not being ready promises to be very expensive, as improperly coded claims will almost certainly be rejected without payment…
Lindstrom's Perspective

Personal knowledge, experience often guide recommendations regarding supplements

Ocular Surgery News U.S. Edition, April 10, 2014
Richard L. Lindstrom, MD
Nutritional supplements and their role in preventing or mitigating systemic or ocular disease remain for me an area of much confusion.
Lindstrom's Perspective

Better drug delivery devices needed to improve patient outcomes

Ocular Surgery News U.S. Edition, May 10, 2014
Richard L. Lindstrom, MD
The application of an eye drop remains the primary method for treating a vast array of eye diseases, primarily of the anterior segment, including…
Lindstrom's Perspective

IRIS Registry expected to benefit physicians, patients and all of ophthalmology

Ocular Surgery News U.S. Edition, March 10, 2014
Richard L. Lindstrom, MD
The federal and state governments are now the No. 1 purchaser of health care in America. They, like any purchaser of goods and services, want good…
Lindstrom's Perspective

One cataract surgeon’s regimen: Intracameral antibiotic in combination with topical antibiotic in every case

Ocular Surgery News U.S. Edition, March 25, 2014
Richard L. Lindstrom, MD
Intracameral antibiotic use for prophylaxis against endophthalmitis following cataract surgery has been proven, in my opinion, beyond a reasonable…
Lindstrom's Perspective

One surgeon’s impressions after 2 years of cross-linking experience

Ocular Surgery News U.S. Edition, February 25, 2014
Richard L. Lindstrom, MD
In this commentary I would like to discuss my last 2 years’ experience working in the CXLUSA investigator-sponsored study of epithelium-on…
Lindstrom's Perspective

Learning process ongoing for corneal collagen cross-linking

Ocular Surgery News U.S. Edition, February 10, 2014
Richard L. Lindstrom, MD
No commercial method of corneal collagen cross-linking, or CXL, is currently approved in the U.S. However, CXL is commercially available in most…